Laboratories can help clinicians deliver patient care with confidence for all stages of heart failure (HF) with Access BNP, a highly sensitive and specific assay that aids clinicians in the:
The Access BNP is a high-quality assay with an analytical sensitivity of 1 pg/mL. The assay demonstrates general specificity of 98%. Watch the webinar to meet the experts.
This high-performance assay can be used across all Beckman Coulter immunoassay analyzers, including, Access 2, DxI 600, and DxI 800.
Access BNP provides valuable clinical insights to aid in the diagnosis of heart failure and left ventricular dysfunction
American College of Cardiology (ACC) / American Heart Association (AHA) / HeartFailure Society of America (HFSA) Guideline for the Management of Heart Failure.
In the areas highlighted in green, BNP has the highest evidence and support for both diagnosis and prognosis (monitoring).
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Thank you for your submission!
Reliability matters.
Fits in small laboratories with space constraints to deliver fast and reliable results.
Simplicity matters.
Gives technologists the benefit of ease of use without sacrificing throughput.
Scalability matters.
Supports the expanding needs of your growing laboratory.
